**5. Conclusions**

Several IVD assays have been developed for the diagnosis of COVID-19. The gold standard for the confirmatory clinical diagnosis is the RT-PCR assay, while the mass population screening has only been feasible with rapid Ag tests. The rapid molecular tests have further extended the RT-PCR based COVID-19 diagnosis at POC settings. The POC molecular test (ID NOW™) from Abbott is a breakthrough in IVD testing. A large number of serology IVD tests, such as automated CLIA, manual ELISA, and LFIA, have further enabled the detection of anti-SARS-CoV-2 Ab in COVID-19 patients and suspects. The ongoing research efforts and continuous advances in the field and complementary technologies will lead to improved IVD tests for COVID-19 in the near future.
